Why High Potency Matters More Than Ever: The New Market And Scientific Landscape Of Precision Medicines

Explore the scientific and commercial forces shaping precision medicines

High potency is no longer restricted to niche oncology products but has become a foundation to present and future drug development driven by the rapid growth of targeted therapies such as bioconjugates — antibody-drug conjugates being one of the fastest expanding segments in the industry, with CAGRs well over 10%, radiopharmaceuticals (>15%) and other, increasingly potent Small Molecules that have pushed containment boundaries well beyond Occupational Exposure Bands (OEB) 4 and 5.

Yet, in spite of increased demand and announced investments, many organizations underestimate the complexity of developing and manufacturing these precision medicines. Success is no longer simply about meeting containment requirements; it requires the expertise to safely onboard, develop, and scale increasingly complex programs.

In this webinar, expert speakers from Lupin Manufacturing Solutions will examine both the commercial and scientific considerations shaping the future of precision medicines.

You’ll learn about:

• How the rapid growth of ADCs, radiopharmaceuticals and other precision medicines is transforming the high-potency manufacturing landscape
• Why developing high-potency products requires more than meeting containment standards
• What sponsors should consider when selecting a manufacturing partner for high-potency programs
• Practical approaches to HPAPI containment, process development and scale-up
• The unique scientific and manufacturing challenges associated with payload-linker chemistry

download Register now to attend